Lexeo Therapeutics, Inc. (LXEO) Accumulated Expenses (2022 - 2023)
Lexeo Therapeutics' Accumulated Expenses history spans 2 years, with the latest figure at $11.8 million for Q3 2023.
- For Q3 2023, Accumulated Expenses changed N/A year-over-year to $11.8 million; the TTM value through Sep 2023 reached $11.8 million, changed N/A, while the annual FY2022 figure was $6.4 million, N/A changed from the prior year.
- Accumulated Expenses for Q3 2023 was $11.8 million at Lexeo Therapeutics, up from $6.4 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $11.8 million in Q3 2023 and bottomed at $6.4 million in Q4 2022.